<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Antimicrobial prophylaxis for prevention of surgical site infection following gastrointestinal procedures in adults
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Antimicrobial prophylaxis for prevention of surgical site infection following gastrointestinal procedures in adults
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Antimicrobial prophylaxis for prevention of surgical site infection following gastrointestinal procedures in adults
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Deverick J Anderson, MD, MPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel J Sexton, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anthony Harris, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Keri K Hall, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Aug 30, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1191970238">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The rate of surgical site infections (SSIs) is low for most surgical procedures. Because of the relatively large surgical volume in many community hospitals, SSIs are the most common health care-associated infection [
         <a href="#rid1">
          1
         </a>
         ]. The United States Centers for Disease Control and Prevention has developed criteria that define SSI as infection related to an operative procedure that occurs at or near the surgical incision within 30 days of the procedure or within 90 days if prosthetic material is implanted at surgery [
         <a href="#rid2">
          2
         </a>
         ]. SSIs are often localized to the incision site but can also extend into deeper adjacent structures.
        </p>
        <p>
         Gastrointestinal procedures are among the highest risk procedures for SSI due to the presence of intraluminal bacteria. According to data published by the National Healthcare Safety Network, rates of SSI following bile duct, liver, or pancreatic surgery are as high as 10 per 100 procedures. Rates of SSI following colon surgery are approximately 5 per 100 procedures, and rates of SSI following gallbladder surgery are 0.7 per 100 procedures [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         Issues related to prevention of SSI following gastrointestinal procedures will be reviewed here. Issues related to epidemiology of SSI and general principles of SSI risk and prevention such as maintaining normothermia, glucose control, and supplemental oxygen are discussed further separately. (See
         <a class="medical medical_review" href="/z/d/html/112216.html" rel="external">
          "Risk factors for impaired wound healing and wound complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">
          "Antimicrobial prophylaxis for prevention of surgical site infection in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4044.html" rel="external">
          "Overview of control measures for prevention of surgical site infection in adults"
         </a>
         .)
        </p>
        <p>
         Specific preventative measures related to surgical techniques including the use of wound protectors in gastrointestinal surgery are also discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4044.html" rel="external">
          "Overview of control measures for prevention of surgical site infection in adults", section on 'Surgical technique'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/120681.html" rel="external">
          "Overview of the evaluation and management of surgical site infection", section on 'Measures to reduce risk'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1191970271">
         <span class="h1">
          ANTIMICROBIAL PROPHYLAXIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are two key components of antimicrobial prophylaxis for prevention of SSI following gastrointestinal procedures: antibiotic selection and timing of administration (to optimize tissue concentration at the time of surgery). The choice of agents depends on the type of procedure, as discussed in the following sections  (
         <a class="graphic graphic_table graphicRef65369" href="/z/d/graphic/65369.html" rel="external">
          table 1
         </a>
         ). Timing of administration is discussed separately (see
         <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">
          "Antimicrobial prophylaxis for prevention of surgical site infection in adults", section on 'Timing'
         </a>
         ). Additional antimicrobial prophylaxis should be administered immediately prior to surgery even in patients who are receiving parenteral therapy as treatment for a known or suspected appendicitis or for an infection such as diverticulitis or a bowel perforation in order to assure that therapeutic antibiotic levels are present during the surgical procedure.
        </p>
        <p class="headingAnchor" id="H2235476">
         <span class="h2">
          Gastroduodenal procedures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antimicrobial prophylaxis with
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         is warranted for patients undergoing clean-contaminated procedures during which the lumen of the intestinal tract is entered [
         <a href="#rid4">
          4,5
         </a>
         ]. These include ulcer resection, carcinoma resection, perforation repair, gastric outlet stricture repair, percutaneous endoscopic gastrostomy (PEG) insertion, pancreaticoduodenectomy (Whipple procedure), and bariatric surgical procedures. (See
         <a class="medical medical_review" href="/z/d/html/15161.html" rel="external">
          "Partial gastrectomy and gastrointestinal reconstruction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15166.html" rel="external">
          "Total gastrectomy and gastrointestinal reconstruction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/88861.html" rel="external">
          "Gastrostomy tubes: Placement and routine care"
         </a>
         .)
        </p>
        <p>
         For patients undergoing clean procedures such as selective vagotomy and antireflux procedures, antimicrobial prophylaxis is warranted only for patients at increased risk for SSI in the setting of such procedures. Risk factors include [
         <a href="#rid6">
          6-9
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diminished gastric acidity (eg, patients on acid-suppression therapy)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gastroduodenal perforation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diminished gastrointestinal motility
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Esophageal obstruction
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gastric outlet obstruction
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gastric bleeding
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Class 2 obesity
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         American Society of Anesthesiologists classification ≥3  (
         <a class="graphic graphic_table graphicRef87504" href="/z/d/graphic/87504.html" rel="external">
          table 2
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Malignancy
        </p>
        <p>
        </p>
        <p>
         SSI rates in patients not receiving antimicrobial prophylaxis are 6 percent after vagotomy and drainage, 13 percent after gastric ulcer procedures, 7 to 17 percent after gastric cancer procedures [
         <a href="#rid10">
          10,11
         </a>
         ], 8 percent for Whipple procedure [
         <a href="#rid12">
          12
         </a>
         ], and 24 to 26 percent after PEG insertion [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         The most common organisms cultured from SSIs after gastroduodenal procedures are coliforms (
         <em>
          Escherichia coli
         </em>
         ,
         <em>
          Proteus
         </em>
         species,
         <em>
          Klebsiella
         </em>
         species), staphylococci, streptococci, enterococci, and occasionally
         <em>
          Bacteroides
         </em>
         species.
        </p>
        <p>
         Appropriate antibiotics are summarized in the table  (
         <a class="graphic graphic_table graphicRef65369" href="/z/d/graphic/65369.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H2235486">
         <span class="h2">
          Biliary tract procedures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antimicrobial prophylaxis with
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         is warranted in patients undergoing open biliary tract procedures. Alternative agents include other cephalosporins (
         <a class="drug drug_general" data-topicid="9222" href="/z/d/drug information/9222.html" rel="external">
          cefotetan
         </a>
         ,
         <a class="drug drug_general" data-topicid="9223" href="/z/d/drug information/9223.html" rel="external">
          cefoxitin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">
          ceftriaxone
         </a>
         ) or
         <a class="drug drug_general" data-topicid="8745" href="/z/d/drug information/8745.html" rel="external">
          ampicillin-sulbactam
         </a>
         .
        </p>
        <p>
         For low-risk patients undergoing elective laparoscopic cholecystectomy, we agree with guidelines that no antimicrobial prophylaxis is necessary [
         <a href="#rid8">
          8,13-16
         </a>
         ]. However, some surgeons and UpToDate surgical contributors give antimicrobial prophylaxis to all patients undergoing cholecystectomy. More detailed discussion of this issue is found elsewhere (See
         <a class="medical medical_review" href="/z/d/html/3685.html" rel="external">
          "Laparoscopic cholecystectomy", section on 'Antibiotics'
         </a>
         .)
        </p>
        <p>
         Routine antimicrobial prophylaxis is not warranted for patients undergoing endoscopic retrograde cholangiopancreatography [
         <a href="#rid17">
          17
         </a>
         ], even in patients thought to have biliary tract stones or distal bile duct stricture [
         <a href="#rid18">
          18
         </a>
         ]. Antimicrobial prophylaxis is warranted in patients with cholangitis, biliary obstruction, and incomplete drainage [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
         Organisms most commonly associated with infection after biliary tract procedures include
         <em>
          E. coli
         </em>
         ,
         <em>
          Klebsiella
         </em>
         species, and enterococci; less frequently, other gram-negatives, streptococci, and staphylococci are isolated. Anaerobes are occasionally reported, most commonly
         <em>
          Clostridium
         </em>
         species. Increasing antimicrobial resistance has been observed among pathogens causing intraabdominal infections, with up to 40 percent of
         <em>
          E. coli
         </em>
         resistant to
         <a class="drug drug_general" data-topicid="8745" href="/z/d/drug information/8745.html" rel="external">
          ampicillin-sulbactam
         </a>
         and fluoroquinolones [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         Appropriate antibiotics are summarized in the table  (
         <a class="graphic graphic_table graphicRef65369" href="/z/d/graphic/65369.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H2240388">
         <span class="h2">
          Pancreatic procedures
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, guidelines for biliary tract surgery may also be applied to pancreatic procedures  (
         <a class="graphic graphic_table graphicRef65369" href="/z/d/graphic/65369.html" rel="external">
          table 1
         </a>
         ). The risk of SSI is increased in the setting of endoscopic or percutaneous biliary or pancreatic drainage procedures done prior to pancreatic surgery [
         <a href="#rid21">
          21
         </a>
         ]. Therefore, antimicrobial prophylaxis prior to the pancreatic procedure should be expanded to cover microorganisms recovered from biliary drains. (See
         <a class="medical medical_review" href="/z/d/html/5660.html" rel="external">
          "Surgical resection of lesions of the body and tail of the pancreas"
         </a>
         .)
        </p>
        <p>
         A pragmatic open-label randomized controlled trial compared the use of
         <a class="drug drug_general" data-topicid="9777" href="/z/d/drug information/9777.html" rel="external">
          piperacillin-tazobactam
         </a>
         for antimicrobial prophylaxis to
         <a class="drug drug_general" data-topicid="9223" href="/z/d/drug information/9223.html" rel="external">
          cefoxitin
         </a>
         in 778 patients undergoing pancreatoduodenectomy [
         <a href="#rid22">
          22
         </a>
         ]. This trial was terminated at an interim analysis due to a decrease in SSI with piperacillin-tazobactam (19.8 versus 32.8 percent; P&lt;0.001). While these data suggest the use of piperacillin-tazobactam leads to improved outcomes, these findings have limitations and must be interpreted in context. Patients in this trial had a high rate of SSI in both arms that may limit generalizability. In addition, the comparator arm used a second-line agent. Finally, the impact of expanded coverage with piperacillin-tazobactam on antimicrobial resistance and the microbiome is unknown.
        </p>
        <p class="headingAnchor" id="H2235520">
         <span class="h2">
          Appendectomy procedures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Uncomplicated appendicitis consists of an acutely inflamed appendix. Complicated appendicitis consists of perforated or gangrenous appendicitis, including peritonitis or abscess formation. (See
         <a class="medical medical_review" href="/z/d/html/1383.html" rel="external">
          "Management of acute appendicitis in adults"
         </a>
         .)
        </p>
        <p>
         Antimicrobial prophylaxis is warranted in the setting of uncomplicated appendicitis [
         <a href="#rid23">
          23,24
         </a>
         ]; a reasonable regimen is a first-generation cephalosporin (
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         ) plus
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         . Patients with complicated appendicitis should receive preoperative antibiotics and continue therapy for at least five days [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         Mean SSI rates for appendectomy reported by the National Healthcare Safety Network (NHSN) in 2009 were 1.2 percent for risk categories 0 and 1 and 3.5 percent for risk categories 2 and 3 [
         <a href="#rid3">
          3
         </a>
         ]. Laparoscopic appendectomy has been reported to produce lower rates of incisional SSIs than open appendectomy, although the rate of organ/space SSIs (ie, intraabdominal abscesses) appears to be increased with laparoscopic appendectomy [
         <a href="#rid15">
          15,25
         </a>
         ].
        </p>
        <p>
         The most common organisms isolated from SSIs after appendectomy are anaerobic and aerobic gram-negative enteric organisms.
         <em>
          Bacteroides fragilis
         </em>
         is the most commonly cultured anaerobe, and
         <em>
          E. coli
         </em>
         is the most frequent aerobe. Aerobic and anaerobic streptococci,
         <em>
          Staphylococcus
         </em>
         species, and
         <em>
          Enterococcus
         </em>
         species have also been reported.
        </p>
        <p>
         Appropriate antibiotics are summarized in the table  (
         <a class="graphic graphic_table graphicRef65369" href="/z/d/graphic/65369.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H4897234">
         <span class="h2">
          Small intestine procedures
         </span>
         <span class="headingEndMark">
          —
         </span>
         For small bowel surgery without obstruction, antimicrobial prophylaxis with
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         is warranted. For small bowel surgery in the setting of obstruction, additional coverage for anaerobic pathogens is warranted  (
         <a class="graphic graphic_table graphicRef65369" href="/z/d/graphic/65369.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         Small intestine procedures include incision or resection of the small intestine, including enterectomy with or without intestinal anastomosis or enterostomy, intestinal bypass, and strictureplasty; it does not include small-to-large bowel anastomosis. Mean SSI rates for small bowel procedures reported by the NHSN in 2009 were 3.4 percent for NHSN risk category 0 and 6.7 percent for NHSN risk categories 1, 2, and 3 [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         Data on antimicrobial prophylaxis for small bowel surgery are limited; the role of antimicrobial prophylaxis is inferred from its efficacy in other clean-contaminated procedures. Microorganisms isolated from SSIs after small bowel surgery include gram-negative enteric organisms (aerobic and anaerobic) and gram-positive species such as streptococci, staphylococci, and enterococci [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2235527">
         <span class="h2">
          Hernia repair procedures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antimicrobial prophylaxis with
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         is warranted for patients undergoing hernioplasty (prosthetic mesh repair of hernia) or herniorrhaphy (suture repair of hernia)  (
         <a class="graphic graphic_table graphicRef65369" href="/z/d/graphic/65369.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid27">
          27-29
         </a>
         ]. The most common organisms isolated from SSI after hernia repair are aerobic gram-positive organisms and aerobic streptococci, staphylococci, and enterococci [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
         Issues related to antimicrobial prophylaxis prior to hernia repair are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3687.html" rel="external">
          "Overview of treatment for inguinal and femoral hernia in adults", section on 'Antibiotic prophylaxis'
         </a>
         .)
        </p>
        <p>
         Issues related to mesh graft infection following hernia repair are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/15100.html" rel="external">
          "Wound infection following repair of abdominal wall hernia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/89384.html" rel="external">
          "Complications of inguinal and femoral hernia repair", section on 'Deep incisional/mesh infection'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3254375">
         <span class="h2">
          Colorectal procedures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intravenous antimicrobial prophylaxis for colorectal procedures is warranted with
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         plus
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         or a second-generation cephalosporin (
         <a class="drug drug_general" data-topicid="9223" href="/z/d/drug information/9223.html" rel="external">
          cefoxitin
         </a>
         or
         <a class="drug drug_general" data-topicid="9222" href="/z/d/drug information/9222.html" rel="external">
          cefotetan
         </a>
         ) [
         <a href="#rid31">
          31
         </a>
         ]. We prefer cefazolin plus metronidazole due to increasing
         <em>
          E. coli
         </em>
         resistance to second-generation cephalosporins. Dosing is summarized in the table  (
         <a class="graphic graphic_table graphicRef65369" href="/z/d/graphic/65369.html" rel="external">
          table 1
         </a>
         ). Intravenous antimicrobial prophylaxis significantly reduces SSI rates and mortality rates; one pooled analysis of 26 trials noted SSI rates of 4.5 versus 11.2 for treatment and control groups, respectively [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
         Ideally, antimicrobial prophylaxis provides appropriate coverage without being overly broad. For example, the combination of
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         and
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         provides appropriate coverage for both aerobic gram-negative enteric bacilli and anaerobes [
         <a href="#rid8">
          8
         </a>
         ]. Several other agents can provide adequate surgical prophylaxis, but provide no advantage over less broad options and potentially lead to a higher risk of adverse events, such postoperative
         <em>
          Clostridioides
         </em>
         <em>
          difficile
         </em>
         infection [
         <a href="#rid33">
          33
         </a>
         ]. For example, the combination of a second- or third-generation cephalosporin plus metronidazole is no more effective than combination of cefazolin and metronidazole [
         <a href="#rid34">
          34
         </a>
         ]. Routine use of third- or fourth-generation cephalosporins for prophylaxis can also lead to emergence of resistant organisms [
         <a href="#rid35">
          35
         </a>
         ]. Carbapenems are effective for surgical prophylaxis; however, their use may increase the risk of subsequent colonization or infection from resistant organisms such as carbapenem-resistant Enterobacteriaceae [
         <a href="#rid36">
          36,37
         </a>
         ].
        </p>
        <p>
         The approach to selecting antimicrobial surgical prophylaxis for patients known to be colonized with drug-resistant pathogens must be individualized. In a prospective cohort study of 3600 patients undergoing elective colorectal surgery who had received standard antibiotic prophylaxis with a cephalosporin and
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         , a greater proportion of patients with than without fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae had SSI caused by the resistant organism (7.2 versus 1.6 percent, odds ratio 4.23, 95% CI 1.70-10.56) [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
         The infecting organisms in colorectal procedures are derived from the bowel lumen, where there are high concentrations of organisms.
         <em>
          B. fragilis
         </em>
         and
         <em>
          E. coli
         </em>
         are the most frequently isolated pathogens from infected surgical sites after colon procedures.
         <em>
          B. fragilis
         </em>
         and other obligate anaerobes are the most frequently isolated organisms from the bowel, with concentrations 1000 to 10,000 times higher than those of aerobes [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
         The benefit of topical antibiotics and other antiseptics for prevention of SSI is uncertain. One meta-analysis of randomized studies examining the efficacy of topical application of both antibiotics (such as
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         sponges) and antiseptics (such as
         <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">
          chlorhexidine
         </a>
         ) applied to open incisions or immediately after wound closure to reduce the risk of SSI following colorectal procedures concluded that some agents showed benefit in reducing the risk of a SSI, but the evidence of benefit was inconsistent and of low to moderate quality [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
         Issues related to bowel preparation and standardized protocols for colorectal surgery are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/15261.html" rel="external">
          "Overview of colon resection", section on 'Bowel preparation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15006.html" rel="external">
          "Enhanced recovery after colorectal surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2394919624">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/115161.html" rel="external">
          "Society guideline links: Prevention of surgical site infections in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2238036">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – Surgical site infections (SSIs) are an important cause of health care-associated infection. They may be localized to the incision site or extend into adjacent deeper structures. Gastrointestinal procedures are among the highest risk procedures for SSI due to the presence of intraluminal bacteria. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antibiotic selection
         </strong>
         – There are two key components of antimicrobial prophylaxis for prevention of SSI following gastrointestinal procedures: antibiotic selection and timing of administration. The choice of agents depends on the type of procedure  (
         <a class="graphic graphic_table graphicRef65369" href="/z/d/graphic/65369.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Antimicrobial prophylaxis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients undergoing clean-contaminated procedures during which the lumen of the intestinal tract is entered, antimicrobial prophylaxis with
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         is warranted. For patients undergoing clean procedures such as selective vagotomy and antireflux procedures, antimicrobial prophylaxis is warranted only for patients at increased risk for SSI in the setting of such procedures. (See
         <a class="local">
          'Gastroduodenal procedures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients undergoing open biliary tract procedures, antimicrobial prophylaxis with
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         is warranted. We agree with guidelines that antimicrobial prophylaxis is not warranted in low-risk patients undergoing elective laparoscopic cholecystectomy, but some experts give antibiotics to all patients undergoing cholecystectomy. (See
         <a class="local">
          'Biliary tract procedures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In the setting of uncomplicated appendicitis, antimicrobial prophylaxis is warranted; reasonable regimens include a cephalosporin with anaerobic activity (
         <a class="drug drug_general" data-topicid="9223" href="/z/d/drug information/9223.html" rel="external">
          cefoxitin
         </a>
         or
         <a class="drug drug_general" data-topicid="9222" href="/z/d/drug information/9222.html" rel="external">
          cefotetan
         </a>
         ) or a first-generation cephalosporin (
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         ) plus
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         . Patients with complicated appendicitis should receive preoperative antibiotics and continue therapy for at least five days. (See
         <a class="local">
          'Appendectomy procedures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For small bowel surgery without obstruction, antimicrobial prophylaxis with
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         is warranted. For small bowel surgery in the setting of obstruction, additional coverage for anaerobic pathogens is warranted. (See
         <a class="local">
          'Small intestine procedures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients undergoing hernioplasty (prosthetic mesh repair of hernia) or herniorrhaphy (suture repair of hernia), antimicrobial prophylaxis with
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         is warranted. The risk of SSI is higher in hernioplasty compared with herniorrhaphy. (See
         <a class="local">
          'Hernia repair procedures'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For colon procedures, intravenous antimicrobial prophylaxis is warranted with a second-generation cephalosporin (
         <a class="drug drug_general" data-topicid="9223" href="/z/d/drug information/9223.html" rel="external">
          cefoxitin
         </a>
         or
         <a class="drug drug_general" data-topicid="9222" href="/z/d/drug information/9222.html" rel="external">
          cefotetan
         </a>
         ) or
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         plus
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         . (See
         <a class="local">
          'Colorectal procedures'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Lewis SS, Moehring RW, Chen LF, et al. Assessing the relative burden of hospital-acquired infections in a network of community hospitals. Infect Control Hosp Epidemiol 2013; 34:1229.
          </a>
         </li>
         <li class="breakAll">
          April 2013 CDC/NHSN Protocol Corrections, Clarification, and Additions http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf (Accessed on July 10, 2013).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009; 37:783.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jafri NS, Mahid SS, Minor KS, et al. Meta-analysis: antibiotic prophylaxis to prevent peristomal infection following percutaneous endoscopic gastrostomy. Aliment Pharmacol Ther 2007; 25:647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma VK, Howden CW. Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy. Am J Gastroenterol 2000; 95:3133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett 2009; 7:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis RT, Goodall RG, Marien B, et al. Efficacy and distribution of single-dose preoperative antibiotic prophylaxis in high-risk gastroduodenal surgery. Can J Surg 1991; 34:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013; 14:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sjöstedt S, Levin P, Malmborg AS, et al. Septic complications in relation to factors influencing the gastric microflora in patients undergoing gastric surgery. J Hosp Infect 1989; 13:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petrosillo N, Drapeau CM, Nicastri E, et al. Surgical site infections in Italian Hospitals: a prospective multicenter study. BMC Infect Dis 2008; 8:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watanabe A, Kohnoe S, Shimabukuro R, et al. Risk factors associated with surgical site infection in upper and lower gastrointestinal surgery. Surg Today 2008; 38:404.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yeo CJ, Cameron JL, Sohn TA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 1999; 229:613.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang WT, Lee KT, Chuang SC, et al. The impact of prophylactic antibiotics on postoperative infection complication in elective laparoscopic cholecystectomy: a prospective randomized study. Am J Surg 2006; 191:721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koc M, Zulfikaroglu B, Kece C, Ozalp N. A prospective randomized study of prophylactic antibiotics in elective laparoscopic cholecystectomy. Surg Endosc 2003; 17:1716.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Varela JE, Wilson SE, Nguyen NT. Laparoscopic surgery significantly reduces surgical-site infections compared with open surgery. Surg Endosc 2010; 24:270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siddiqui K, Khan AF. Comparison of frequency of wound infection: open vs laparoscopic cholecystectomy. J Ayub Med Coll Abbottabad 2006; 18:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harris A, Chan AC, Torres-Viera C, et al. Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 1999; 31:718.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Hazel SJ, Speelman P, Dankert J, et al. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial. Ann Intern Med 1996; 125:442.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mallery JS, Baron TH, Dominitz JA, et al. Complications of ERCP. Gastrointest Endosc 2003; 57:633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baquero F, Hsueh PR, Paterson DL, et al. In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect (Larchmt) 2009; 10:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jethwa P, Breuning E, Bhati C, et al. The microbiological impact of pre-operative biliary drainage on patients undergoing hepato-biliary-pancreatic (HPB) surgery. Aliment Pharmacol Ther 2007; 25:1175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Angelica MI, Ellis RJ, Liu JB, et al. Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial. JAMA 2023; 329:1579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006; 43:322.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev 2005; :CD001439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sauerland S, Lefering R, Neugebauer EA. Laparoscopic versus open surgery for suspected appendicitis. Cochrane Database Syst Rev 2004; :CD001546.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schnüriger B, Inaba K, Eberle BM, et al. Microbiological profile and antimicrobial susceptibility in surgical site infections following hollow viscus injury. J Gastrointest Surg 2010; 14:1304.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           den Hartog D, Dur AH, Tuinebreijer WE, Kreis RW. Open surgical procedures for incisional hernias. Cochrane Database Syst Rev 2008; :CD006438.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanchez-Manuel FJ, Lozano-García J, Seco-Gil JL. Antibiotic prophylaxis for hernia repair. Cochrane Database Syst Rev 2012; :CD003769.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yin Y, Song T, Liao B, et al. Antibiotic prophylaxis in patients undergoing open mesh repair of inguinal hernia: a meta-analysis. Am Surg 2012; 78:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanchez VM, Abi-Haidar YE, Itani KM. Mesh infection in ventral incisional hernia repair: incidence, contributing factors, and treatment. Surg Infect (Larchmt) 2011; 12:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson RL, Glenny AM, Song F. Antimicrobial prophylaxis for colorectal surgery. Cochrane Database Syst Rev 2009; :CD001181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baum ML, Anish DS, Chalmers TC, et al. A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls. N Engl J Med 1981; 305:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee S, Prasad P, Lin M, et al. Ertapenem Prophylaxis Associated With an Increased Risk of Clostridium difficile Infection Among Surgical Patients. Infect Control Hosp Epidemiol 2015; 36:1351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skipper D, Karran SJ. A randomized prospective study to compare cefotetan with cefuroxime plus metronidazole as prophylaxis in elective colorectal surgery. J Hosp Infect 1992; 21:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Song F, Glenny AM. Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomised controlled trials. Health Technol Assess 1998; 2:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Itani KM, Wilson SE, Awad SS, et al. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med 2006; 355:2640.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sexton DJ. Carbapenems for surgical prophylaxis? N Engl J Med 2006; 355:2693.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dubinsky-Pertzov B, Temkin E, Harbarth S, et al. Carriage of Extended-spectrum Beta-lactamase-producing Enterobacteriaceae and the Risk of Surgical Site Infection After Colorectal Surgery: A Prospective Cohort Study. Clin Infect Dis 2019; 68:1699.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nichols RL. Prophylaxis for intraabdominal surgery. Rev Infect Dis 1984; 6 Suppl 1:S276.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson RL, Iqbal NM, Kravets A, et al. Topical antimicrobial prophylaxis in colorectal surgery for the prevention of surgical wound infection: a systematic review and meta-analysis. Tech Coloproctol 2018; 22:573.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 13984 Version 34.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24113613" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Assessing the relative burden of hospital-acquired infections in a network of community hospitals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24113613" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Assessing the relative burden of hospital-acquired infections in a network of community hospitals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20004811" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17311597" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Meta-analysis: antibiotic prophylaxis to prevent peristomal infection following percutaneous endoscopic gastrostomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11095330" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19461558" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Antimicrobial prophylaxis for surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2025800" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Efficacy and distribution of single-dose preoperative antibiotic prophylaxis in high-risk gastroduodenal surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23461695" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Clinical practice guidelines for antimicrobial prophylaxis in surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2567313" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Septic complications in relation to factors influencing the gastric microflora in patients undergoing gastric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18328101" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Surgical site infections in Italian Hospitals: a prospective multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18560962" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Risk factors associated with surgical site infection in upper and lower gastrointestinal surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10235519" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16720138" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The impact of prophylactic antibiotics on postoperative infection complication in elective laparoscopic cholecystectomy: a prospective randomized study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12802644" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : A prospective randomized study of prophylactic antibiotics in elective laparoscopic cholecystectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19533235" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Laparoscopic surgery significantly reduces surgical-site infections compared with open surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17348307" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Comparison of frequency of wound infection: open vs laparoscopic cholecystectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10604613" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8779455" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12709688" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Complications of ERCP.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18831681" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17451563" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : The microbiological impact of pre-operative biliary drainage on patients undergoing hepato-biliary-pancreatic (HPB) surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37078771" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16804848" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16034862" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Antibiotics versus placebo for prevention of postoperative infection after appendicectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15495014" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Laparoscopic versus open surgery for suspected appendicitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20499202" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Microbiological profile and antimicrobial susceptibility in surgical site infections following hollow viscus injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18646155" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Open surgical procedures for incisional hernias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22336793" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Antibiotic prophylaxis for hernia repair.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22524778" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Antibiotic prophylaxis in patients undergoing open mesh repair of inguinal hernia: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21767146" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Mesh infection in ventral incisional hernia repair: incidence, contributing factors, and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19160191" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Antimicrobial prophylaxis for colorectal surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7266633" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26278576" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Ertapenem Prophylaxis Associated With an Increased Risk of Clostridium difficile Infection Among Surgical Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1351498" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : A randomized prospective study to compare cefotetan with cefuroxime plus metronidazole as prophylaxis in elective colorectal surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9621130" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomised controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17182989" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Ertapenem versus cefotetan prophylaxis in elective colorectal surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17182996" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Carbapenems for surgical prophylaxis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30204851" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Carriage of Extended-spectrum Beta-lactamase-producing Enterobacteriaceae and the Risk of Surgical Site Infection After Colorectal Surgery: A Prospective Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6372034" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Prophylaxis for intraabdominal surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30019145" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Topical antimicrobial prophylaxis in colorectal surgery for the prevention of surgical wound infection: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
